Evidence map›Paper›PMID 36612782›Full record

ArticleInternational journal of environmental research and public health2022

Development and Validation of a Mobile Application as an Adjuvant Treatment for People Diagnosed with Long COVID-19: Protocol for a Co-Creation Study of a Health Asset and an Analysis of Its Effectiveness and Cost-Effectiveness.

Mario Samper-Pardo, Sandra León-Herrera, Bárbara Oliván-Blázquez, Belén Benedé-Azagra, Rosa Magallón-Botaya, Isabel Gómez-Soria, Estela Calatayud, Alejandra Aguilar-Latorre, Fátima Méndez-López, Sara Pérez-Palomares and 4 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Cost-Effectiveness of a Personalised Self-Management Intervention for People Living With Long Covid: The LISTEN Randomised Controlled Trial.Health expectations : an international journal of public participation in health care and health policy · 2025
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Mario Samper-PardoDepartment of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Sandra León-HerreraDepartment of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Bárbara Oliván-BlázquezDepartment of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0001-6565-9699
Belén Benedé-AzagraInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.
Rosa Magallón-BotayaDepartment of Medicine, University of Zaragoza, 50009 Zaragoza, Spain.
Isabel Gómez-SoriaInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.ORCID 0000-0002-0061-3312
Estela CalatayudInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.ORCID 0000-0002-4307-796X
Alejandra Aguilar-LatorreInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.ORCID 0000-0003-2683-7346
Fátima Méndez-LópezInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.ORCID 0000-0002-6409-9041
Sara Pérez-PalomaresInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.
Ana Cobos-RincónDepartment of Nursing, University of La Rioja, 26004 Logroño, Spain.ORCID 0000-0002-4121-8992
Diana Valero-ErrazuDepartment of Psychology and Sociology, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0002-3252-076X
Lucia Sagarra-RomeroGAIAS Research Group, Faculty of Health Sciences, University San Jorge, 50830 Zaragoza, Spain.ORCID 0000-0001-5929-6449
Raquel Sánchez-RecioInstitute for Health Research Aragon (IISAragon), 50009 Zaragoza, Spain.
Universidad de Zaragoza · ESInstituto de Investigación Sanitaria Aragón · ESUniversidad de La Rioja · ESUniversidad San Jorge · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyse the overall effectiveness and cost-efficiency of a mobile application (APP) as a community health asset (HA) with recommendations and recovery exercises created bearing in mind the main symptoms presented by patients in order to improve their quality of life, as well as other secondary variables, such as the number and severity of ongoing symptoms, physical and cognitive functions, affective state, and sleep quality.

methodsThe first step was to design and develop the technologic community resource, the APP, following the steps involved in the process of recommending health assets (RHA). After this, a protocol of a randomised clinical trial for analysing its effectiveness and cost-efficiency as a HA was developed. The participants will be assigned to: (1st) usual treatment by the primary care practitioner (TAU), as a control group; and (2nd) TAU + use of the APP as a HA and adjuvant treatment in their recovery + three motivational interviews (MI), as an interventional group. An evaluation will be carried out at baseline with further assessments three and six months following the end of the intervention. DISCUSSION: Although research and care for these patients are still in their initial stages, it is necessary to equip patients and health care practitioners with tools to assist in their recovery. Furthermore, enhanced motivation can be achieved through telerehabilitation (TR).

Indexed as

COVID-19Mobile ApplicationsCost-Benefit AnalysisHumansPost-Acute COVID-19 SyndromeQuality of LifeRandomized Controlled Trials as TopicAPPco-creationcost-efficiencyeffectivenesshealth assetlong COVID-19primary health care

Identifiers

PMID36612782
PMCPMC9819090
OpenAlexW4313327220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.